-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide: Pulmonary hypertension is abnormally dangerous, how to choose medication.
a few days ago saw a post reported that a young woman had taken nearly 10 years of diet pills, this year due to the appearance of discomfort symptoms to go to the hospital to check, actually found out the pulmonary artery hypertension, left and right atrial deformation, the heart than the normal three times! After reviewing the literature, pharmacists found that studies showed that some people who took diet products containing appetite suppressants were significantly more likely to develop pulmonary hypertension.
appetite inhibitors (e.g., sibutramine, fenfluramin and its derivatives, etc.) will destroy a 5-serotonin transport system in the blood vessels of the lungs, leading to vasculature, which may cause the growth of pulmonary vascular cells to grow out of control, thus promoting the development of pulmonary arterial hypertension.
a preliminary understanding of the pulmonary arterial hypertension, pulmonary hypertension refers to the abnormal state of pulmonary vascular pressure increase swells more than a certain number.
once the circulatory system of blood flow in the lungs malfunctions, it can seriously affect the blood supply to the heart and can even lead to right heart failure and life-threatening.
lack of oxygen due to inadequate pulmonary circulation, the patient's lips often appear blue-purple, so also known as "blue lips."
2018 the American College of Thoracic Physicians (ACCP) has updated its guidelines for the diagnosis and treatment of pulmonary hypertension (hereinafter referred to as the "Guidelines"), and for the first time, a new concept for comprehensive management of pulmonary arterial patients, covering targeted drug therapy, cardiopulmonary rehabilitation, palliative care, supportive therapy (drug-supported therapy and oxygen therapy), and prevention, based on drug therapy.
the current list of commonly used pulmonary hypertension treatment drugs , traditional drug treatment ( table 1 ) 2 , targeted drugs ( table 2 ) If the results of acute pulmonary vascular dilation test negative , recommended targeted drug treatment , mainly for endothelial cell dysfunction of the three ways to intervene , stretch blood vessels , improve the condition , delay the deterioration of the disease time .
summarize sizing the treatment of pulmonary hypertension a wide range of drugs, expensive, evidence-based research data to be further improved, doctors usually consider the patient's economic conditions, body tolerance and other conditions to work out a personalized plan, and every 3 to 6 months to re-evaluate the patient, in order to adjust the treatment plan in a timely manner, improve the quality of life of patients.
.